-+ 0.00%
-+ 0.00%
-+ 0.00%

PolyPid says SHIELD II data show D-PLEX100 doxycycline release lasts up to 32 days

PUBT·04/13/2026 13:15:51
Listen to the news
PolyPid says SHIELD II data show D-PLEX100 doxycycline release lasts up to 32 days
  • PolyPid scheduled new Phase 3 SHIELD II pharmacokinetic data for D-PLEX100 presentation at ESCMID Global 2026 in Munich on April 19.
  • Analysis supports sustained local antibiotic delivery at surgical incision site with limited systemic exposure, reinforcing intended product profile for post-surgical infection prevention.
  • Update adds clinical support for D-PLEX100 differentiation versus standard systemic prophylaxis during period when infections most often emerge.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPid Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604130915PRIMZONEFULLFEED9687009) on April 13, 2026, and is solely responsible for the information contained therein.